Piśmiennictwo
1. Orjuela D, Puerto G, Mejia G, Castro C, Garzon MC, Garcia LM, Hernandez E, Ribon W, Rodriguez G: Cutaneous tuberculosis after mesotherapy: a report of six cases. Biomedica 30:321 326, 2010
2. Cramer JA: A systematic review of adherence with medications for diabetes. Diabetes Care 27:1218 1224, 2004
3. Sankar UV, Lipska K, Mini GK, Sarma PS, Thankappan KR: The adherence to medications in diabetic patients in rural Kerala, India. Asia Pac J Public Health. Electronically published ahead of print on 14 February 2013 (doi:10.1177/1010539513475651)
4. Egede LE, Gebregziabher M, Dismuke CE, Lynch CP, Axon RN, Zhao Y, Mauldin PD: Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care 35:2533-2539, 2012
5. Currie CJ, Peyrot M, Morgan CL,Poole CD, Jones SJ, Rubin RR, Burton CM, Evans M: The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care 35:1279-1284, 2012
6. Broadbent E, Donkin L, Stroh JC: Illness and treatment perceptions are associated with adherence to medications, diet, and exercise in diabetic patients. Diabetes Care 34:338 340, 2011
7. Parchman ML, Zeber JE, Palmer RF: Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med 8:410 417, 2010
8. American Diabetes Association: Insulin administration. Diabetes Care 25 (Suppl.1):S112–S115, 2002
9. Ginsberg BH, Parkes JL, Sparacino C: The kenetics of insulin administration by insulin pens. Horm Metab Res 26:584 587, 1994
10. American Diabetes Association: Insulin delivery. Diabetes Forecast Resource Guide,January 2008, p. RG17 RG29